Sam Chun Dang Pharm to sign eye drop export agreements of more than KRW 1 trillion in U.S. and Europe

Sam Chun Dang Pharm has drawn attention of the industry as signing export agreements of its eye drops to advanced markets, like the U.S. and Europe. There are three reasons why this is.

According to Sam Chun Dang Pharm, the company signed export agreements of generics – not new drugs nor biologics like anticancer drugs – worth of KRW 1.11 trillion to the U.S.(KRW 400 billion for BPI, KRW 700 b...